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Introduction
Verapamil is an off-label first-line drug in prevention of
cluster headache (CH) but little is known about the opti-
mal rate of dose escalation. The safety profile of slow
dose increment in 80mg intervals has been previously
documented. It is possible to achieve the effective dosage
earlier with fast escalation, although the safety and toler-
ability are of concerns.
Objective
To compare the electrocardiographic abnormalities and
other adverse events between fast (escalation of verapamil
by 120mg every two weeks) and slow titration (by 80mg)
of verapamil in CH treatment.
Methods
Electrocardiograms (ECGs) at baseline and every two
weeks in parallel with the increment of the drug were per-
formed in patients attending our clinic. Medical records
and ECGs performed in CH patients between 2007 and
2011 were retrospectively reviewed.
Results
Of 169 patients, 80 followed the fast and 89 the slow regi-
men. The slow regimen group differed from the fast regi-
men group in terms of: higher proportion of chronic CH
(84% vs 64%, p=0.002), duration of verapamil use (median
35 vs 10 months, p<0.001) and maximum dosage of vera-
pamil achieved (mean 711mg ±272 vs 616mg ±257,
p=0.021). Eighty-three (49%) patients showed ECG
changes: bradycardia in 60 (36%), first-degree atrioventri-
cular block (AVB) in 22 (13%), second-degree AVB in 1
(1%), third-degree AVB in 2 (1%), junctional rhythm in
7 (4%) and bundle branch block in 3 (2%) patients. The
rate of arrhythmias did not differ between two groups.
Verapamil was stopped only in second- and third-degree
AVB. The rate of drug discontinuation due to arrhythmias
or non-ECG adverse events did not differ between groups.
Conclusion
The occurrence of verapamil-related serious cardiac
arrhythmias was rare in patients adopting fast titration
regimen. Our data support the safety and tolerability of
rapid escalation of verapamil in patients with CH. Regular
ECG assessment is essential throughout the therapy.
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